We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+38.21%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$108M
AUM Growth
–
Cap. Flow
+$94.4M
Cap. Flow %
87.56%
Top 10 Hldgs %
39.31%
Holding
80
New
80
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$5.94M
2
DRRX
DURECT Corp
DRRX
+$5.04M
3
CLDR
Cloudera, Inc.
CLDR
+$4.58M
4
AVNW icon
Aviat Networks
AVNW
+$3.29M
5
SFE
Safeguard Scientifics, Inc.
SFE
+$3.12M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 36.62%
2 Technology 17.3%
3 Financials 11.58%
4 Consumer Discretionary 8.7%
5 Energy 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
1
Cytokinetics
CYTK
$10B
$6.75M 6.26%
+325,000
New +$5.94M
CLDR
2
DELISTED
Cloudera, Inc.
CLDR
$5.56M 5.16%
+400,000
New +$4.58M
DRRX
3
DELISTED
DURECT Corp
DRRX
$5.49M 5.09%
+265,000
New +$5.04M
ATER icon
4
Aterian
ATER
$7.03M
$4.91M 4.55%
+23,750
New +$2.74M
AVNW icon
5
Aviat Networks
AVNW
$256M
$3.95M 3.67%
+231,536
New +$3.29M
TGB
6
Trekor Metals
TGB
$3.36B
$3.5M 3.24%
+2,650,000
New +$2.81M
CLPT icon
7
ClearPoint Neuro
CLPT
$474M
$3.34M 3.09%
+210,000
New +$1.88M
SFE
8
DELISTED
Safeguard Scientifics, Inc.
SFE
$3.19M 2.96%
+500,000
New +$3.12M
NMRK icon
9
Newmark Group
NMRK
$2.87B
$2.92M 2.7%
+400,000
New +$2.47M
ALCO icon
10
Alico
ALCO
$300M
$2.79M 2.59%
+90,000
New +$2.77M
INTT icon
11
inTEST
INTT
$142M
$2.6M 2.41%
+400,200
New +$2.03M
INTC icon
12
Intel
INTC
$473B
$2.49M 2.31%
+50,000
New +$2.44M
IMGN
13
DELISTED
Immunogen Inc
IMGN
$2.42M 2.24%
+375,000
New +$2.19M
ARKR icon
14
Ark Restaurants
ARKR
$19.8M
$2.23M 2.07%
+115,000
New +$1.48M
RNWK
15
DELISTED
RealNetworks Inc
RNWK
$2.11M 1.95%
+1,350,000
New +$1.98M
FOLD
16
DELISTED
Amicus Therapeutics
FOLD
$2.08M 1.93%
+90,000
New +$1.84M
BGC icon
17
BGC Group
BGC
$5.76B
$1.9M 1.76%
+475,000
New +$1.66M
TALO icon
18
Talos Energy
TALO
$2.78B
$1.85M 1.72%
+225,000
New +$1.75M
GILD icon
19
Gilead Sciences
GILD
$181B
$1.75M 1.62%
+30,000
New +$1.81M
TAST
20
DELISTED
Carrols Restaurant Group, Inc.
TAST
$1.62M 1.51%
+258,565
New +$1.65M
RLGT icon
21
Radiant Logistics
RLGT
$408M
$1.59M 1.48%
+275,000
New +$1.54M
RBCAA icon
22
Republic Bancorp
RBCAA
$1.86B
$1.59M 1.48%
+44,205
New +$1.54M
AVTA
23
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.59M 1.48%
+100,000
New +$1.22M
PTCT icon
24
PTC Therapeutics
PTCT
$5.85B
$1.53M 1.42%
+25,000
New +$1.47M
CADE
25
DELISTED
Cadence Bancorporation
CADE
$1.48M 1.37%
+90,000
New +$1.19M
1
2 3 4

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $158M AUM 33.7% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

CM Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for CM Management, which disclosed 80 positions worth $108M. Its ten largest holdings account for 39% of the portfolio.

Its largest position is Cytokinetics: 325,000 shares worth $6.75M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, followed by Technology and Financials.

  • CM Management's largest Q4 2020 buy was Cytokinetics: 325,000 shares worth $6.75M.
  • CM Management's ten largest holdings make up 39% of its $108M portfolio in Q4 2020.
  • CM Management disclosed 80 positions in Q4 2020, its first 13F filing on record.

Based on CM Management's 13F filing for Q4 2020, filed 4 Feb 2021.